抗疟疾转基因 z-bo 2020-09-21 361

　　Researchers in the United States recently announced that they have developed a recombinant mosquito in the laboratory that carries an anti-malaria gene that can be passed on to offspring.

　　Researchers at the University of California used the most popular CRISPR gene editing technology in the proceedings of the National Academy of Sciences to transfer the anti-Plasmodium gene into a specific embryonic germ cell line in Hamadarika on the 21st. The report range has been inserted. Hamadaraka is the main malaria vector in Asia. The results showed that the gene produced antibodies to Plasmodium and was inherited by 99.5% of the offspring of transgenic hamadaraka. Professor Anthony James, head of research at the University of California, Irvine, said in a statement that this is an important first step in using CRISPR gene editing technology to transform malaria-resistant mosquitoes. Real hope.

　　Many experts in the field of biotechnology believe that this result is very important. Peter Atkinson, professor of genetics at the University of California, Riverside, said that if field trials prove that the gene reduces the ability of mosquitoes to carry malaria, the technology will be an important tool in the fight against malaria. This will be a very important development in this regard. Malaria is caused by a parasite called Plasmodium, which spreads after being bitten by an infected mosquito. According to statistics from the World Health Organization, there are about 200 million malaria cases and about 600,000 deaths in the world every year. Most cases and deaths occur in Africa.